Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
ozuriftamab vedotin (BA3021) - BioAtla
ENB003 - ENB Therap
mecbotamab vedotin (BA3011) - BioAtla
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Biosci
http://clinicaltrials.gov/ct2/show/NCT04918186
Jan 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next